Biopharmaceuticals targeting osteo-renal indications, including the complications of chronic kidney disease and dialysis, bone and cartilage repair and regeneration, and general dental and oral care
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of Acologix plus 4709 other start-ups.
